Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
attention_candidates
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_narrative_members
intel_narratives
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_6a3119bde019 in signals
id
sig_6a3119bde019
Primary key.
TEXT
event_id
481670
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_unusual_volume_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.nasdaq.com/articles/aclarion-authorized-repurchase-25-mln-shares","as_of":"2026-04-22T13:12:40.941923+00:00","canonical_url":"https://www.rttnews.com/3641290/aclarion-authorized-to-repurchase-up-to-2-5-mln-of-shares.aspx","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/aclarion-authorized-repurchase-25-mln-shares","article_chars":757,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_26031ef4af4dfad9","canonical_host":"rttnews.com","canonical_is_aggregator":false,"canonical_url":"https://www.rttnews.com/3641290/aclarion-authorized-to-repurchase-up-to-2-5-mln-of-shares.aspx","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-22T13:13:46.378836+00:00","extraction_method":"trafilatura","fetched_description":"(RTTNews) - Aclarion, Inc.(ACON), a healthcare technology company, said on Wednesday that its board has authorized a share repurchase program of up to $2.5 million of shares. The company plans to execute the share repurchase drive over the next 12 months.","fetched_title":"Aclarion Authorized To Repurchase Up To $2.5 Mln Of Shares | Nasdaq","final_url":"https://www.nasdaq.com/articles/aclarion-authorized-repurchase-25-mln-shares","html_truncated":false,"paywall_likely":false,"publisher_domain":"rttnews.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/aclarion-authorized-repurchase-25-mln-shares","source_event_id":"evt_d3b92c64d672","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"fp":"687f6ab489efcb2f","kind":"unusual_volume","published_at":"2026-04-22T12:58:39+00:00","publisher_domain":"rttnews.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["Wednesday"],"entities":[{"asset_class":"equity","name":"Aclarion, Inc.","relevance":"primary","symbol":"ACON","type":"company"},{"asset_class":"unknown","name":"Brent Ness","relevance":"secondary","symbol":"","type":"person"}],"event_type":"other","information_gaps":["Unusual volume delta details are not provided: baseline volume, current volume, volume ratio vs average, and direction are missing.","The signal\u2019s confirmation status (whether unusual volume is confirmed by news) cannot be determined from the provided text; the article content does not mention volume.","No explicit catalyst hypothesis tied to unusual volume is stated in the text beyond the repurchase authorization itself."],"key_facts":["Aclarion authorized a share repurchase program of up to $2.5 million of shares.","The repurchase program is planned to be executed over the next 12 months.","Aclarion intends to fund the program using existing cash and cash equivalents.","CEO Brent Ness said the company believes its shares represent compelling value at current levels and described the program as flexible and opportunistic to enhance shareholder value.","CEO statement also links the program to continuing investment in clinical adoption and expansion of Nociscan."],"numeric_claims":[{"label":"repurchase_program_size_usd","value":"2.5 million"},{"label":"repurchase_execution_horizon","value":"12 months"}],"primary_claim":"Aclarion\u2019s board authorized a share repurchase program for up to $2.5 million of its shares, to run over the next 12 months.","relevance_score":0.45,"sentiment":"positive","source_quality":"medium","summary":"Aclarion (ACON) announced its board authorized a share repurchase program of up to $2.5 million, to be executed over the next 12 months. The company says it will fund the program with existing cash and cash equivalents.","topics":["share repurchase authorization","capital allocation","funding source","shareholder value"]},"source":"Nasdaq Markets","source_domain":"rttnews.com","summary":"(RTTNews) - Aclarion, Inc.(ACON), a healthcare technology company, said on Wednesday that its board has authorized a share repurchase program of up to $2.5 million of shares. The company plans to execute the share repurchase drive over the next 12 months.","tickers":["ACON"],"title":"Aclarion Authorized To Repurchase Up To $2.5 Mln Of Shares","url":"https://www.rttnews.com/3641290/aclarion-authorized-to-repurchase-up-to-2-5-mln-of-shares.aspx"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_ingestor
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_d3b92c64d672"]}
TEXT
dedupe_key
signal_enriched:discovery_unusual_volume_delta:7980d6703e093545
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-22T13:12:40.941923+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel